These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 22648705

  • 21. Improved outcomes in patients with osteogenic sarcoma of the head and neck.
    Patel SG, Meyers P, Huvos AG, Wolden S, Singh B, Shaha AR, Boyle JO, Pfister D, Shah JP, Kraus DH.
    Cancer; 2002 Oct 01; 95(7):1495-503. PubMed ID: 12237918
    [Abstract] [Full Text] [Related]

  • 22. The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: results of a phase II study.
    Arpaci F, Ataergin S, Ozet A, Erler K, Basbozkurt M, Ozcan A, Komurcu S, Ozturk B, Celasun B, Kilic S, Kuzhan O.
    Cancer; 2005 Sep 01; 104(5):1058-65. PubMed ID: 15999369
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE, Children's Oncology Group.
    J Clin Oncol; 2008 Feb 01; 26(4):633-8. PubMed ID: 18235123
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
    Bacci G, Mercuri M, Longhi A, Ferrari S, Bertoni F, Versari M, Picci P.
    Eur J Cancer; 2005 Sep 01; 41(14):2079-85. PubMed ID: 16115755
    [Abstract] [Full Text] [Related]

  • 27. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS, Gorlick R, Bukata S, Chou A, Morris CD, Boland PJ, Huvos AG, Meyers PA, Healey JH.
    Cancer; 2006 Oct 01; 107(7):1607-16. PubMed ID: 16933325
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities.
    Machak GN, Tkachev SI, Solovyev YN, Sinyukov PA, Ivanov SM, Kochergina NV, Ryjkov AD, Tepliakov VV, Bokhian BY, Glebovskaya VV.
    Mayo Clin Proc; 2003 Feb 01; 78(2):147-55. PubMed ID: 12583525
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma.
    Jeon DG, Kong CB, Cho WH, Song WS, Cho SH, Choi SW, Lee SY.
    J Surg Oncol; 2014 Mar 01; 109(3):275-9. PubMed ID: 24243222
    [Abstract] [Full Text] [Related]

  • 38. [Osteosarcoma lung metastases. Survival after chemotherapy and surgery].
    Farfalli GL, Albergo JI, Lobos PA, Smith DE, Streitenberger PD, Pallotta Rodríguez MG, Aponte-Tinao LA.
    Medicina (B Aires); 2015 Mar 01; 75(2):87-90. PubMed ID: 25919869
    [Abstract] [Full Text] [Related]

  • 39. Spontaneous necrosis and additional tumor necrosis induced by preoperative chemotherapy for osteosarcoma: a case-control study.
    Song WS, Jeon DG, Cho WH, Kong CB, Cho SH, Lee SY, Lee SY.
    J Orthop Sci; 2015 Jan 01; 20(1):174-9. PubMed ID: 25355661
    [Abstract] [Full Text] [Related]

  • 40. Tumor volume change after chemotheraphy as a predictive factor of disease free survival for osteosarcoma.
    Moon SH, Shin KH, Suh JS, Yang WI, Noh JK, Hahn SB.
    Yonsei Med J; 2005 Feb 28; 46(1):119-24. PubMed ID: 15744814
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.